Clinical trial EZH-202
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Cancers | |
---|---|
Organ | Soft tissue |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | Epizyme |
EudraCT Identifier | 2015-002469-41 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02601950 |
Inclusion criteria | after standard therapy |
Last update |